Ginkgo Bioworks Holdings Inc (NYSE:DNA) shares are trading lower on Friday. The company released its third-quarter financial ...

Ginkgo Bioworks Holdings Inc (DNA) showcases strong financial positioning and AI-driven innovation, despite facing revenue hurdles in cell engineering.

Ginkgo Bioworks Holdings, Inc. (NYSE: DNA, "Ginkgo") today announced its results for the third quarter ended September 30, 2025. The update, including a webcast slide presentation with additional ...

Ginkgo reaffirmed its full-year 2025 revenue guidance of $167 million to $187 million, with Cell Engineering revenue expected to be $117 million to $137 million and Biosecurity revenue expected to be ...

The goal of the project is to develop novel approaches that strengthen and reduce the costs of domestic mAb biomanufacturing to protect against and treat infection by filoviruses.

To truly deliver on their promise, nitrogen-fixing microbes need to up their game, says Ginkgo ag bio head, Michael Miile.

Ginkgo Bioworks (NYSE: DNA) today announced that the company has extended its multi-year strategic partnership with Bayer to ...

Q: I have a female ginkgo tree and my (lucky) next-door neighbor has two males. A new ginkgo has self-planted itself in a nice spot in the front yard. Is there any way to tell at this tender age ...